Skip to Content

← See all Stay Awake Maximum Strength brands

Stay Awake Maximum Strength by Walgreen Company

Dosage form: tablet
Ingredients: CAFFEINE 200mg
Labeler: Walgreen Company
NDC Code: 0363-0226

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Walgreens 44-226

Active ingredient (in each tablet)

Caffeine 200 mg

Purpose

Alertness aid

Uses

helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Warnings

For occasional use only

Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.

Do not use
  • in children under 12 years
  • as a substitute for sleep 

Stop use and ask a doctor if

fatigue or drowsiness persists or continues to recur.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
  • adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

Other information
  • ​​store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • see end flap for expiration date and lot number

Inactive ingredients

corn starch, D&C yellow #10 aluminum lake, dextrose, dicalcium phosphate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silica gel

Questions or comments?

1-800-426-9391

Principal Display Panel

Walgreens

NDC 0363-0226-12

Compare to Vivarin®
active ingredient††

Stay
Awake

CAFFEINE 200 mg / 
ALERTNESS AID

MAXIMUM STRENGTH

• Caffeine for
  mental alertness

• Equal to about a
   cup of coffee

100
TABLETS 

ACTUAL SIZE

††This product is not manufactured or distributed by Meda Consumer Healthcare, owner of the registered trademark Vivarin®.
   50844        ORG041222610

DISTRIBUTED BY: WALGREEN CO.,
200 WILMOT RD., DEERFIELD, IL 60015
100% SATISFACTION GUARANTEED 
walgreens.com  ©2018 Walgreen Co.

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Walgreens 44-226

STAY AWAKE  MAXIMUM STRENGTH
caffeine tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0363-0226
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAFFEINE (CAFFEINE) CAFFEINE200 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 
FD&C YELLOW NO. 6 
MAGNESIUM STEARATE 
MICROCRYSTALLINE CELLULOSE 
STARCH, CORN 
DEXTROSE 
ANHYDROUS DIBASIC CALCIUM PHOSPHATE 
SILICON DIOXIDE 
Product Characteristics
ColorYELLOWScoreno score
ShapeROUNDSize11mm
FlavorImprint Code44;226
Contains    
Packaging
#Item CodePackage Description
1NDC:0363-0226-212 BLISTER PACK in 1 CARTON
18 TABLET in 1 BLISTER PACK
2NDC:0363-0226-105 BLISTER PACK in 1 CARTON
28 TABLET in 1 BLISTER PACK
3NDC:0363-0226-083 BLISTER PACK in 1 CARTON
38 TABLET in 1 BLISTER PACK
4NDC:0363-0226-121 BOTTLE, PLASTIC in 1 CARTON
4100 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34011/21/1996
Labeler - Walgreen Company (008965063)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867894MANUFACTURE(0363-0226)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.038154464PACK(0363-0226)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867837PACK(0363-0226)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.868734088PACK(0363-0226)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.967626305PACK(0363-0226)

 
Walgreen Company

← See all Stay Awake Maximum Strength brands

Medically reviewed on Jul 9, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide